Neuroinflammatory cytokine signaling

Neuroinflammatory cytokine signaling is a complex biological process involving the production and transmission of signaling proteins within the central nervous system (CNS) to coordinate immune responses. This pathway is primarily initiated by the activation of microglia and astrocytes, which release pro-inflammatory cytokines such as Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 beta (IL-1β), and Interleukin-6 (IL-6) in response to pathological stimuli (Nature Reviews Immunology, 2015). These cytokines bind to specific cell-surface receptors, triggering intracellular cascades like the NF-kB and JAK/STAT pathways that regulate gene expression related to cell survival and inflammation (Frontiers in Immunology, 2019). While acute signaling is a protective mechanism for tissue repair, chronic dysregulation of these cytokine networks is a major driver of neurodegeneration and synaptic loss in diseases like Alzheimer's and Multiple Sclerosis (Pharmacology & Therapeutics, 2020). Therapeutic strategies often target specific nodes within this signaling network, such as individual cytokines or their receptors, to dampen the neurotoxic effects of chronic inflammation. Because this term describes a broad physiological process involving numerous distinct proteins rather than a single molecular entity, it is classified as a signaling pathway rather than a discrete therapeutic target.

Other names

Neuroinflammation pathwayCytokine-mediated neuroinflammationCNS cytokine signalingNeuroinflammatory cascade

Modulation of neuroinflammatory responses through the inhibition of pro-inflammatory cytokines (e.g., TNF, IL-1, IL-6) or their receptors, or the inhibition of downstream intracellular signaling kinases like JAK/STAT and NF-kB to mitigate neuronal damage.